Mary Wilson
Well-known member
by OnCuba Staff
August 28, 2020
Cuba announced work on a new COVID-19 vaccine candidate, in addition to reporting good results with a new clinical trial that uses rectal ozone therapy in patients confirmed with SARS-CoV-2, reported the Agencia Cubana de Noticias news agency.
Vicente V?rez, director of the Finlay Institute, said progress is being made in the second vaccine project; with the same Soberana 01 antigen, but on a different platform.
“We are finishing the formulation this week and filling next week, it’s a different vaccine,” explained V?rez, and assured that the trial is giving “very interesting responses” in animals.
For her part, the director of research, development and innovation of the National Center for Scientific Research, Sarahi Mendoza, referred to a study with ozone therapy in patients with COVID-19.
She said that the use of this therapy in the conventional treatment of COVID-19 “increased by 40% the number of patients with a negative PCR test on the fifth day.”
Cited by Cubadebate, Mendoza added that “it was possible to reduce the hospital stay by 3.5 days on average per patient. Ozone therapy,” she pointed out, “was safe, well tolerated, and there were no biosafety incidents.”
https://oncubanews.com/en/cuba/cuba-announces-progress-in-second-covid-19-vaccine-candidate/
August 28, 2020
Cuba announced work on a new COVID-19 vaccine candidate, in addition to reporting good results with a new clinical trial that uses rectal ozone therapy in patients confirmed with SARS-CoV-2, reported the Agencia Cubana de Noticias news agency.
Vicente V?rez, director of the Finlay Institute, said progress is being made in the second vaccine project; with the same Soberana 01 antigen, but on a different platform.
“We are finishing the formulation this week and filling next week, it’s a different vaccine,” explained V?rez, and assured that the trial is giving “very interesting responses” in animals.
For her part, the director of research, development and innovation of the National Center for Scientific Research, Sarahi Mendoza, referred to a study with ozone therapy in patients with COVID-19.
She said that the use of this therapy in the conventional treatment of COVID-19 “increased by 40% the number of patients with a negative PCR test on the fifth day.”
Cited by Cubadebate, Mendoza added that “it was possible to reduce the hospital stay by 3.5 days on average per patient. Ozone therapy,” she pointed out, “was safe, well tolerated, and there were no biosafety incidents.”
https://oncubanews.com/en/cuba/cuba-announces-progress-in-second-covid-19-vaccine-candidate/